In vitro experiments have shown that the presence of the CLDN18-ARHGAP26 fusion gene increases the migration and invasion ability of gastric cancer cells [8, 9, 15], as well as the resistance of tumor cells to chemotherapy drugs [9]. Here, ARHGAP26 is linked to neoplasm.